Anti-IL-5/5R versus anti-IL4R switching strategies for uncontrolled severe asthma treated by anti-IL5/5R : A target trial emulation (RAMSES-Switch)First published 14/06/2023 Last updated 14/06/2023 EU PAS number: EUPAS105374StudyOngoing
Assistance Publique - Hôpitaux de Paris (AP-HP)France First published: 01/02/2024Last updated 01/02/2024 InstitutionHospital/Clinic/Other health care facility